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ABSTRACT
BACKGROUND
The solitary thyroid nodule are common in outpatient surgical
department of our institution, it may be benign or malignant, it has to be
characterised properly for optimal management.
AIM AND OBJECTIVE
The aim of our study is
1. To stress the importance of  FNAC as diagnostic tool
2. To study the age, sex distribution of cases in our institution
3. To study percentage of benign and malignancy in solitary nodular
goitre.
METHODS
In this study we analysed our institutional surgical OPD patient for
one year October 2016-sptember 2017. All the patient presented with
solitary thyroid nodule included in the study, all the patient individually
assessed investigated with FNAC and Ultrasound.
The patient were treated appropriative therapeutically and surgically like
hemithyroidectomy or  total  thyroidectomy with or without neck dissection.
RESULTS
In our study of 100 patients 8 (8%) were male and 92 (92%) females,
patient with solitary nodular goitre age wise <30 yrs 2 (8%) males and 22
(90%) females,30-60 yrs 5 (7%) males and 61 (92%) females >60 yrs 1
(10%) male and 9 (90%) female. The most common age group of both male
and female is 30-60 yrs. The nodule were found more in right lobe of thyroid
48 (48 %) out of 100 patients, 47 (47%) of left low and in isthmus for 5 (5%)
patients.
Incidence of malignant nodule out of 100 were 21 (21%) of which 3
(15%) male patient and 18 (88%) female patient. In male out of 3 (33%) one
papillary carcinoma and 2 (66%) follicular carcinoma. In females out of 18,
13 (72%) papillary carcinoma and 5 (27%) follicular carcinoma. Rest of 79
cases were benign lesion, the solitary nodule in males are propionately more
malignant.
All malignant patient underwent total thyroidectomy with lymphnode
dissection while patient with benign lesion underwent Hemithyroiectomy.
CONCLUSION
 The best modality of investigation for thyroid based on our study found to
be Fine needle aspiration cytology, easy to perform and cheaper.
 In our study conducted among the  patient visiting our Hospital  the
commonest thyroid disease is solitary nodular goitre
 Out of 100 patients 92 females and 8 males were affected which shows
disease of female predominance
 Most  of affected people were middle aged 30-60 years, which shows
disease of mid age group
 Most of lesion benign 79 cases out of 100  which proves benign nodules
are common presentation
 The reported 21 malignant cases papillary carcinoma of 14 cases and 7
follicular carcinoma, which show the common thyroid malignancy is
papillary carcinoma
 The reported 8 cases in males 3 were malignant which shows
propionately solitary nodule in male are more malignant
 The patients with benign lesion underwent hemithyroidectomy of 79
cases, while patient with malignant and suspicious underwent total
thyroidectomy with lymphnode dissection.
KEY WORDS :
Solitary nodular goitre, hemithyroidectomy, total thyroidectomy, fine
needle aspiration cytology, papillary carcinoma, follicular carcinoma,
recurrent laryngeal nerve.
1INTRODUCTION
Thyroid is the Greek word meaning “shield shaped” In our body
thyroid gland maintains level of metabolism in the tissues that is optimal for
their normal function. Thyroid hormone stimulates oxygen consumption of
most of cells of our body. It regulates metabolism of lipids, carbohydrate and
necessary for normal growth and maturation. More number of thyroid
nodules are found incidentally .i.e.1% in men and 5% in women. Ultrasound
detects 20-70% of patient with thyroid nodule. Most of them are Benign but
5-15% are malignant. The modality of investigation in this study is Fine
needle aspiration cytology which has 86%sensitivity and 90% specificity.
Thyroid cancer represents about three percent of all malignancies. The
frequency of malignancy is higher in children than in adult. The use of
external beam ionising radiation for acne, tonsillitis as shown increase
incidence of thyroid malignancy after 5 years of exposure in children.
2THE AIM OF OUR STUDY IS
1. To stress the importance of  FNAC as diagnostic tool
2. To study the age, sex distribution of cases in our institution
3. To study percentage of benign and malignancy in solitary nodular
goitre.
3MATERIALS AND METHODS
This follow up study by fine needle aspiration cytology was conducted
between October 2016-september 2017 In Government Vellore medical
college of both General surgery and Pathology department.
Fine needle Aspiration cytology in solitary nodular goitre include all
age group of male and female. All screened cases were studied detail with
clinical examination and investigation, when FNAC/clinical examination
gave suggestion of malignancy special care has been taken.
STUDY PERIOD:
One year
STUDY DESIGN:
It’s a Prospective study
4MATERIAL USED FOR FNAC:
10CC syringe,
22-24 gauge needle,
Syringe holder
Glass slides
Alcohol
Gauze pad
Adhesive bandage.
5PROCEDURE:
6Patient underwent clinical examination and patient with solitary
nodular goitre included for study and proceeded with fine needle aspiration
cytology. It has been done in supine position with pillow under the neck in
same position minimum 2-4 aspiration has been carried out, the aspirant
transferred to glass slide and some immersed in 70% alcohol and some air
dried. The most common stain used is papanicolaou or wright stain, the
interpretation classified as benign, suspicious of malignancy or malignancy.
Further investigation including thyroid profile (TSH, T3, T4), ultrasound
neck, routine blood investigation were carried out. All patient were before
surgery screened by ENT surgeon to rule out vocal cord paralysis. In
malignancy metastasis workup done includes skeletal survey, liver function
test.
The patient were grouped based on FNAC study into
GROUP 1 – BENIGN:
All patients whose both FNAC and clinical examination shows
features of benign lesion were grouped-1, they may be colloid are
adenamatous goitre.
7GROUP II- SUSPICIOUS MALIGNANCY:
The lesion which comes as follicular adenoma which was
differentiated from malignancy by FNAC were classified under II
GROUP III- MALIGNANT:
- The FNAC proved malignancy
- Hard swelling
- Voice change
- Regional lymphnode involvement
- Swelling fixed to underlying structure
- Difficulty in swallowing
- Difficulty in breathing
- All patient -100 were grouped under this categories based upon the
clinical examination and Fine needle aspiration cytology and
management such as thyroidectomy planned as per diagnosis.
8RESULTS
In our study of 100 patients 8 (8%) were male and 92 (92%) females,
patient with solitary nodular goitre age wise <30 yrs 2 (8%) males and 22
(90%) females,30-60 yrs 5 (7%) males and 61 (92%) females >60 yrs 1
(10%) male and 9 (90%) female. The most common age group of both male
and female is 30-60 yrs. The nodule were found more in right lobe of thyroid
48 (48 %) out of 100 patients, 47 (47%) of left low and in isthmus for 5 (5%)
patients.
Incidence of malignant nodule out of 100 were 21 (21%) of which 3
(15%) male patient and 18 (88%) female patient. In male out of 3 (33%) one
papillary carcinoma and 2 (66%) follicular carcinoma. In females out of 18,
13 (72%) papillary carcinoma and 5 (27%) follicular carcinoma. Rest of 79
cases were benign lesion, the solitary nodule in males are propionately more
malignant.
All malignant patient underwent total thyroidectomy with lymphnode
dissection while patient with benign lesion underwent Hemithyroiectomy.
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DISCUSSION
The best and easy modality of investigation with minimum
complication is FNAC the adequate specimen has been taken by 3-6
aspiration, in our study only the solitary nodule has been taken which was
confirmed by USG and clinical examination. On FNAC basis grouped to
benign, malignant and suspicious of malignancy, the suspicious cases FNAC
repeated and confirmed. The FNAC proved malignant cases planned for total
thyroidectomy with lymphnode dissection. The Solitary nodular goitre
patient with Hypothyroidism or Hyperthyroidism treated and followed
accordingly. The sensitivity of FNAC in diagnosing Papillary carcinoma is
98% but for follicular carcinoma 90% . In our study the benign lesion follow
up HPE report also proved same and Malignant lesion follow up HPE report
malignant.
(1) Fine-Needle Aspiration of the Thyroid: Correlating Suspicious
Cytology Results with Histological Outcomes
Preoperative FNAC was undertaken in 2,692 patients, and the FNAC
result was ‘suspicious for malignancy’ in 94 (3.5 %) patients. Of these, 53
(56.4 %) were malignant, with the majority 44 (83.0 %) being papillary
thyroid cancer. 48 patients went straight to total thyroidectomy, 40 patients
had an initial diagnostic hemithyroidectomy, and 1 patient had a diagnostic
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isthmusectomy. 5 patients required reoperative total thyroidectomy as an
initial procedure. Of the 94 suspicious cases, 55 were reported by an
unknown, presumably non-expert, thyroid cytopathologist. 38 of these
cases were available for review and re-reporting by an experienced
cytopathologist. On review, 28 (73.7 %) were reclassified as cytologically
malignant, and all of these were confirmed as malignant on subsequent
histopathology.
2.(2) Thyroid nodules are commonly diagnosed in adults. Although
rare in children, the risk for thyroid cancer is much higher in the pediatric
population compared with adults. Presenting as either a solitary nodule or a
multinodular goiter, thyroid nodular disease in children requires a thorough
workup that includes a detailed clinical examination comprised of prior
history of thyroid disease in the patient or in their family, history of radiation
exposure, careful palpation of the thyroid and lymph nodes, blood tests,
ultrasonography, and cytological assessment. Thyroid surgery is the gold-
standard treatment for pediatric thyroid nodules; nonetheless, the extent of
surgery remains controversial. Because surgery is not without risk, the
decision matrix necessitates focus on the benefits of surgery for the child
contingent upon all the preoperative exams. New diagnostic technology such
as molecular testing with fine needle aspiration biopsy may help distinguish
between benign and malignant lesions while potentially decreasing surgery
16
for benign disease. The objective of this review is to summarize new
concepts in clinical disease management of nodular thyroid disease in the
pediatric population, including patient history, medical examination, and
diagnosis workup
3.(3) Thyroid nodular disease is very common in the United States, withpalpable nodules occurring in approximately 5% of adults, especially inwomen. Because of the possibility of a single nodule being cancerous(albeit only approximately 5%), a thorough clinical evaluation, includinga detailed history and physical exam, must be undertaken. Fine needleaspiration biopsy is the cornerstone of the laboratory evaluation ofthyroid nodules, and its use in recent years has resulted in a significantdecrease in the number of thyroid surgeries being performed, whileincreasing the yield of malignant lesions of patients who haveundergone operation. The utility of levothyroxine suppression inpatients with benign thyroid nodules continues to be controversial.
4.(4) Fine-needle aspiration biopsy (FNAB) is recommended for the initial
evaluation of thyroid nodule. If a benign cytology is obtained, suppression
therapy with levothyroxine is the first choice in the management of nodular
goitre with a follow-up of nodule size with ultrasonography, but the effects
of FNAB have not been taken into consideration in this approach. We
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aimed at evaluating the effect of FNAB on thyroid volume and other
ultrasonographic dimensions by measurement of these parameters before
and immediately after the procedure, and in later periods, and to clarify the
necessity of regarding the effects of FNAB on thyroid. Forty-six patients
(34 females, 12 males; mean age: 36.3±10.7 yr) with solitary thyroid
nodules were included in the study. The nodules were solid in
ultrasonography, thyroid function tests were normal and results of FNAB
were found as benign cytology. Thyroid hormone suppression therapy was
not initiated. Ultrasonographic measurements were made before FNAB,
repeated immediately after FNAB, and 1 month and 6 months later. There
were no statistically significant changes in the mean thyroid nodule
volume, nodule area and circumference of patients before, immediately
after FNAB, 1 month and 6 months later. Size differences and individual
variability at each time period were analyzed. These parameters changed by
more than 10% in a great majority (69.5–78.2%) of patients, and more than
50% change was observed in 17.3–26.0% of patients. Changes in thyroid
dimensions were bi-directional, both increment and decrement being
noticed. It was thought that this is the reason why there was no significant
change in mean nodule volume, area and circumference. Evaluating the
difference in nodule volume according to ultrasonographic parameters
obtained before FNAB may be misleading because of the individual change
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in these parameters with FNAB. It may be useful to evaluate the nodule
size and volume closely after FNAB to make a true correspondence of
these parameters in the long term.
5.(5) Females constituted 92.5 % (n=617) of the series. The mean age of all
patients was 35.2+/-11.58 years (range, 13 to 90 years). Most patients (93%)
came from highland areas with an average altitude of 2000 to 2600 meters
above sea level. The average duration since patients noticed swelling until
the diagnosis was made was about 4 years. Multinodular bilateral swelling
was the most common clinical finding (44.9%), while solitary nodules
constituted the least common (17.4%). The most common associated
symptom was dyspnoea (20.5%). The most common histopathological
finding was nodular and colloid goitre (62.8%), while malignancy accounted
for 17.7%. Subtotal thyroidectomy was the most frequent procedure, and the
most common postoperative complication was hypocalcaemia.
6.(6) Thyroid carcinoma (TC) is a relatively rare tumour, but it represents the
most frequent form of cancer of the endocrine glands. Epidemiologically
ascertained risk factors are ionising radiation, the presence of thyroid
adenoma and multinodular goiter (MNG). Multinodularity of goiter should
no longer be considered an indicator of probable benign disease. A
retrospective analysis was performed on patients operated of MNG at the
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Unit of Otolaryngology, Sanremo Hospital (Italy) from January 1st 1995 to
December 31st 2002, in order to establish the incidence of carcinoma. The
results of this retrospective study, demonstrate that in 13.7% of the patients
operated for goiter, the presence of a carcinoma was noticed in the definitive
histopathologic examination. Such incidence percentage of MNG is in
accordance with the data reported in published reports. Thus, the authors
conclude that the risk of malignancy in MNG has not to be underestimated,
and that a dominant nodule in MNG should be valued as if it were a solitary
nodule in an otherwise normal gland.
7. Already history, ultrasound and TSH (thyroid-stimulating hormone)
determination do allow a first risk assessment for the further diagnostic
work-up. Fine-needle biopsy (FNB) offers the best sensitivity and
specificity for the distinction between benign and malignant thyroid
nodules. The combination of several clinical and ultrasound criteria and
laboratory determinations (calcitonin) can help with the selection of thyroid
nodules with scintigraphically normal or decreased uptake > 1 cm for FNB.
However, the efficiency of FNB requires sufficient training and experience
of both the cytopathologist and the person performing FNB.
8. Thyroid nodular disease is very common in the United States, with
palpable nodules occurring in approximately 5% of adults, especially in
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women. Because of the possibility of a single nodule being cancerous (albeit
only approximately 5%), a thorough clinical evaluation, including a detailed
history and physical exam, must be undertaken. Fine needle aspiration
biopsy is the cornerstone of the laboratory evaluation of thyroid nodules, and
its use in recent years has resulted in a significant decrease in the number of
thyroid surgeries being performed, while increasing the yield of malignant
lesions of patients who have undergone operation. The utility of
levothyroxine suppression in patients with benign thyroid nodules continues
to be controversial
9. Results
In the present study, rapid enhancement was seen in 87.5% of malignant
cases and washout pattern was seen in 87.5% of malignant STN (p = 0.019).
Only 20% of the benign lesions showed washout pattern (p = 0.0034).
Benign cases demonstrated gradual enhancement in 85% cases as compared
to 12.5% in malignant STN (p = 0.0098).(8)
10. (9) Nodular goiter encompasses a spectrum of diseases from the
incidental asymptomatic small solitary nodule to the large
intrathoracic goiter causing pressure symptoms as well as functional
complaints. The mainstay in the diagnostic evaluation is related to functional
and morphological characterization with serum thyroid-stimulating hormone
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(TSH), ultrasound (US) and other imaging procedures and cytology by fine
needle aspiration (FNA) on the basis of the different diseases. A clinical
classification considering solitary cyst, adenomatous functioning nodule,
follicular lesion and multinodular goiter may be proposed to consider the
alternative therapies other than surgery as TSH suppressive or thyrostatic
treatment, 131I therapy, percutaneous ethanol injection therapy (PEIT) or the
only clinical exam in benignant lesions. Surgery should be advocated for the
treatment of thyroid nodules whenever a patient presents with either pressure
symptoms, hyperthyroidism or follicular/indeterminate cytology. Surgical
approach, intraoperatory strategy and the extension of surgical treatment are
correlated to the different clinical categories. At surgery the frozen section
analysis in case of hemithyroidectomy is of aid to rule out malignancy and to
prevent the reoperation. The surgical treatment of choice in case of
uninodular goiter is lobectomy, total thyroidectomy or near total
thyroidectomy is the correct treatment of multinodular bilateral goiter. The
choice of the treatment must be condivided with the patient.
11.(10) There were 160 multinodular goiters during the study period, out of
which 24 (15.0%) had histologically diagnosed cancer, and 1 out of the
thirteen patients with solitary thyroid nodule (7.6%) had carcinoma. The
ages of the patients with carcinoma ranged from 16 to 65 years, with a mean
age of 38.8 years. Eighteen (72%) were females, and 7 (28%) were males.
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Six out of the 25 cases of carcinoma were detected preoperatively by fine
needle aspiration cytology. Well differentiated follicular carcinoma was the
predominant histological type in 13 (52%) cases, followed by papillary in 10
(40%), medullary carcinoma in 1 (4%) and anaplastic carcinoma in 1 (4%)
patient.
12.(11) Repeat FNAC was benign in 346 patients (86.5%), insufficientfor diagnosis in 42 (10.5%), suspicious in 16 (2.5%) and malignant in 2(0.5%). All diagnostic changes to suspicious malignant cytology tookplace in patients with solitary nodules. Surgery confirmed thyroidcancer in the 2 patients with malignant cytology, in 5 of 10 patientswith suspicious cytology and in none of 39 patients withbenign cytology who underwent surgery for other reasons. Clinicalchanges (size increase or local symptoms) were not related to changesin cytologic diagnosis after a second aspiration, nor with the results ofthe biopsy.
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EMBROLOGY
Thyroid Gland develops from Thyroglossal duct by Invagination
from floor of pharynx. Thyroglossal duct Extends from foramen caecum in
the base of tongue to the neck. This is of endodermal origin. Thyrogobulin
synthesis starts by 8th week of gestation. Iodine trapping and colloid
formation by 12th week of gestation. Calcitonin producing parafollicular
cells develop from 4th pharyngeal pouch and migrates from neural crest . By
6th week of gestation this thyroglossal duct reabsorbed only distal end
remains and matures as pyramidal lobe. The maternal TSH, T3, T4 do not
cross placenta.
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ANATOMY
Thyroid gland weight is around 10-20 grams. It is bilobed structure
lying anterior compartment of the neck at the junction of larynx and trachea
connected by isthmus, Thyroid gland has the highest rate of Blood flow per
gram of tissue of any organ of the body. Thyroid extends lateral to trachea
and oesophagus. The deep investing layer of neck pre-tracheal fascia
encircles the thyroid gland, posteriorly gets condensed to form ligament
Berry attached to cricoids cartilage. It is lined by cuboidal epithelium with
20-40 follicles. Nerves-superior laryngeal nerve travels along with superior
thyroid Artery and inferior thyroid artery accompany recurrent laryngeal
Nerve.
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Blood supply:
The Thyroid gland is supplied by following Arteries, superior thyroid
artery-Branch of External carotid artery. Inferior Thyroid artery-Branch of
Thyrocervical trunk which is branch of subclavian artery. In 5% of
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individuals Thyroid ima artery direct branch of arch of aorta directly
supplies.
Venous Drainage:
The Thyroid gland drained by 3 known veins
The superior thyroid vein drains into internal jugular vein.
The middle thyroid vein drains into internal jugular vein.
The inferior Thyroid vein drains into Brachiocepalic vein.
Lymphatic Drainage:
27
The gland drain into
Pre-tracheal nodes
Para-tracheal nodes
Superior mediasternal nodes
Retropharyngeal nodes
Oesophageal nodes
Upper, middle, lower jugular nodes
Cervical nodes
Sub maxillary node
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MICROSCOPIC FINDINGS
Each gland lobes are made of multiple follicles. Each follicle are
spherical in shape and surrounded by single layer of secretory cells, central
portion of follicle filled with colloid. When the gland is Inactive cells are flat
and here more colloid. When the gland is active Cells are cuboid or
columnar follicles are small and have less
Colloid. Colloid is nothing but condensed Thyroglobulin.
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PHYSIOLOGY
Thyroid gland secretes following Hormones directly into blood stream.
T4-Thyroxin
T3-Tri-iodothyroxin
Reverse T3-Reverse Tri- iodothyronin
Calcitonin-calcium lowering substance.
Thyroid hormone required for 2 weeks are stored in the gland. Most
of thyroid hormone released is T4, it is converted in the peripheral Tissue to
T3. T3 hormone is most active and potent. Reverse T3 is Inactive.
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Hypothalamo-pituitary thyroid axis regulates Thyroid Hormone secretion.
Hypothalamus secretes Thyrotropin Hormone Which acts on anterior
Pituitary and stimulates to secrete TSH,TSH acts on Thyroid gland and
release Thyroid Hormones. There is Negative feedback inhibition System.
TSH is Primary regulator of Thyroid Hormone. Condition that decreases
TSH secretion classified as primary Hypothyroidism. When abnormality
results at Hypothalamus and pituitary results in decreased TSH is called
central Hypothyroidism. In the periphery thyroid T4 is converted to T3 and
Increase affinity peripheral nuclear thyroid hormone receptor Member of
steroid hormone receptor family.80% of circulating Thyroid hormone bind to
thyroxin binding globulin in the periphery. Some of T4 is bound to pre-
albumin and albumin. Only 1% of T3 and T4 are free, rest of are bound. The
Half life of T3 is 12 hours, T4 is 7 days due to efficient binding. Patient with
Thyrotoxicosis have increased adrenergenic activity, the Beta Blockers used
for treatment does not directly inhibit thyroid Hormone synthesis parse the
control sensitivity to Catecholamine’s. Therefore cardiovascular symptoms
such as Increased pulse rate, tremor and anxiety improve but Hyper
metabolic rate remains as, progress with treatment alone.
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THYROID HORMONE SYNTHESIS:
80% of Iodine in the Body is found in the Thyroid gland. In thyroid
follicle iodide get oxidised to iodine and bind tyrosine residue of
thyroglobulin results in formation Iodothyronine namely MIT, DIT, of this
when both DIT combines to form T4.MIT,DIT combines to form T3.rarely
DIT,MIT results in formation of reverse T3 which is inactive.
32
PATHOLOGY
Solitary thyroid nodule
The palpable single nodule in thyroid gland with rest of gland
impalpable or otherwise normal gland is called solitary nodule. The solitary
thyroid malignancy is common around 6-16% of cases. The solitary nodule
commonly due to thyroid adenomas which are follicular type colloid variety,
it does not have potency for micro-invasion, other type fetal-microfollicular
potential for micro-invasion. Embryonal atypical also potential for micro
invasion.
The papillary carcinoma is common, follicular, medullary and
anaplastic are rare. In some cases thyroid cyst or thyroiditis present as
nodular goitre. The solitary nodule 70% are benign, 10%- suspicious of
malignancy, 5% are malignant and 15% are non diagnostic. Some nodule
may be toxic or non toxic based on radioisotope scan, Hot means the
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autonomous toxic nodule, nodule is overactive the surrounding thyroid tissue
is normal and inactive. The warm nodule is normal functioning nodule, the
nodule and surrounding normal thyroid will take up the isotope. Out of 10%
are malignant. The cold nodule are non functioning nodule will not take up
isotope, out of which 20 % are malignant.
The features of  solitary nodule is palpable nodule in one or other
lobe  which is firm and smooth, on examination absent nodule in other part
of  whole gland. The nodule in children and elderly adult are mostly
malignant confirmed by radioisotope scanning, some time the malignant
lesion goes up rapid enlargement, with tracheal deviation confirmed by trail
sign and by x-ray neck. The common site of nodule is junction of isthmus to
thyroid gland. The characters suggesting of malignancy is hard nodule rapid
increase in size, with hoarness of voice, dysphagia, stridor, dyspnoea. There
may be fixity of nodule with neck nodes.
BENIGN NODULE
The benign nodule which is nontoxic observed without any treatment.
There is no hormone treatment, clinical examination is annually to rule out
increase in size of 2mm or 20% in diameter then needs repeated FNAC
followed hemithyroidectomy. When there are compressive symptoms or
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cosmetics hemithyroidectomy can be planned. In follicular adenoma total
thyroidectomy can be done.
MALIGNANT NODULE
In fine needle aspiration cytology comes as papillary carcinoma the
totalthyroidectomy can be done. When there is extracapsular spread with
2cm in size than radioactive iodine can be used, followed by suppressive
dose of thyroxin. When patient operated for follicular adenoma than biopsy
reports as follicular carcinoma with capsular and vascular invasion than total
thyroidectomy can be done after 3 weeks are within 7 days. In medullary
carcinoma along with total thyroidectomy bilateral neck nodal dissection
with central compartment is done.
INDETERMINATE NODULE
In follicular adenoma patient treated with hemithyroidectomy but if
HPE reports for follicular carcinoma with capsular and vascular invasion
than total thyroidectomy done within a week.
In suspicious nodule hemithyroidectomy is done followed frozen section
report total thyroidectomy is done in malignancy, the frozen section is useful
in papillary carcinoma but not in follicular.
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BENIGN THYROID DISEASE:
Hypothyroidism:
Primary Hypothyroidism is failure of thyroid to produce sufficient
Hormone. In some cases production is normal but hormone has limited
activity or resistance.
IODINE DEFICIENCY:
Chronic Iodine deficiency due to decreased intake Leads to decreased
production of hormone. On investigation T3, T4 low and TSH is elevated.
Goitre develops at early ages, it remains Higher in women’s. Thyroid gland
enlargement occurs, Follicular space reduces and follicle distended with
colloids. The follicle became inactive. Necrosis, scarring, Haemorrhage,
fibrosis can occur resulting in enlargement in asymmetric pattern.
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POST RADIATION HYPOTHYROIDISM:
It is seen in patient underwent I131therapy for Graves’s disease, Toxic
Multinodular Goitre or external beam radiation in mediasternal lymphoma.
POSTSURGICAL HYPOTHYROIDISM:
It is commonly seen following subtotal thyroidectomy or total
thyroidectomy.
DRUG INDUCED HYPOTHYROIDISM:
Methimazole, propylthiouracil can cause Hypothyroidism on
treatment of Hyperthyroidism. Some drugs like lithium, Amiodarone and
cytokines can also induce Hypothyroidism.
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THYROIDITIS:
Hashimoto’s thyroiditis
It is autoimmune Thyroiditis, most common cause for Hypothyroidism
in adults mostly seen in Females(10:1) in Hashimoto’s Thyroiditis antibodies
are formed against TSH receptors and Thyroid peroxidase, results in reduced
Thyroid hormone synthesis.
CHRONIC LYMPHOCYTIC THYROIDITIS:
In this condition there will be raised antibodies titre, patient present
with nodular, diffuse or bosselated or rarely subclinical thyroid failure. In
some cases primary myxoedema without thyroid enlargement present as end
stage of pathological process. The onset may be insidious or sudden with
mild hyperthyroidism followed hypothyroidism. The goitre may be lobulated
or localised to one lobe with soft, rubbery, firm or fibrosis in consistency in
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women at menopause rarely develops into papillary or malignant lymphoma.
Patient should be supplemented with thyroxine because some may subside
with hormone therapy. Even after the goitre increase after thyroxine then
steroid can be tried. Thyroidectomy is necessary if thyroid large and produce
discomfort.
GRANULOMATOUS THYROIDITIS :
It is otherwise called as subacute thyroiditis, de quervain’s thyroiditis,
following viral infection, It develops following upper airway infection.
Patient have diffuse swelling in cervical with sudden increase in pain. Some
patient present with fever, fatigue loss of weight, however the disease
process progress. On investigation raised inflammatory markers without
antibodies, normal thyroid profile with low I123 uptake by gland. Some
patient present with hypothyroidism or hyperthyroidism, the treatment is
steroid for two weeks and tapered for next month, if thyroid failure arise
thyroxin can be substituted.
RIEDELS THYROIDITIS
Rare of .5 % goitre where thyroid is replaced with cellular fibrous
tissue, leads to infiltration to adjacent muscle, parathyroid, nerve and vessels.
In this patient may be associated with collagen disease involving fibrosis of
retroperitoneum and mediasternum. The hard goitre with fixity should be
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differentiated from anaplastic carcinoma thyroid by isthumectomy biopsy. It
is treated with steroid, thyroxin and tamoxifen, in early treatment response
is good.
ACUTE SUPPURATIVE THYROIDITIS :
It is due infection of Thyroid following Pyogenic infection of upper
airway. It is very rare.
HYPERTHYROIDISM:
The classical symptoms of Hyperthyroidism Includes sweating,
anxiety, increased appetite, loss of weight, Heat intolerance, palpitation, Hair
loss, Hyper menorrhoea, congestive cardiac failure, ventricular tachycardia
and ventricular fibrillation and high output cardiac failure.
THYROTOXICOSIS:
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Thyrotoxicosis is nothing but hyperthyroidism, symptoms due raised
level of circulating thyroid hormone resulting in manifestation of disease.
The clinical types are
1. GRAVES DISEASE :
It is autoimmune Hyperthyroidism, due to auto Antibodies against
TSH receptor, commonly seen in women 20-40yrs. In Graves disease eyes
are affected mostly, results in proptosis, supraorbital, infraorbital
conjunctival swelling and odema, which leads to opthalmoplegia, diplopia,
optic nerve damage and blindness. 50% of patients have autoimmune
endocrine disease.
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The heart rate is fast in thyrotoxicosis which persists in sleep also. The
cardiac arrhythmia superimposed on sinus tachycardia which results in
multiple extrasystole, paroxysmal atrial tachycardia, paroxysmal atrial
fibrillation, followed atrial fibrillation not responding to digoxin.
MYOPATHY
There is proximal muscle weakness the severe weakness
resembles myasthenia gravis which improve on control of hyperthyroidism.
EYE SIGNS
Some patient develops exopthalmos to some degree is common in
thyrotoxicosis but in true exopthalmos is  proptosis of eye due to infiltration
of retrobulbar tissue with fluid and round cells  resulting in retraction and
spasm of upper eyelid. The widened palpaberal fissure with upper sclera
visible above margin of iris and cornea. When hyperthyroidism is on control
the spasm and retraction disappears. The eye signs improved with beta-
adrenergic blocking drugs, the ophthalmic vein compression results in
oedema of eyes, chemosis, conjunctival injection. The diplopia due to
weakness in elevator muscle (inferior oblique). The severe form called as
malignant exopthalmos. The exopthalmos improved by sleeping and lateral
tarsorrhapy. Patient improves with high dose of steroid.
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LID RETRACTION :
The lower eyelid normal in position, the upper eyelid is higher than normal,
due sympathetic over activity causing the spasm of Muller muscle levator
palpabera superiors.
VON GRAEFE’S SIGN :
The inability of upper eyelid to follow eyeball on looking downward of
examiners fingers.
DALRYMPLE’S SIGN :
Visibility of upper sclera due to retraction of upper eyelid.
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STELLWAG’S SIGN :
Absence of normal blinking, due to widened palpaberal fissure is the first
sign to appear, the lid retraction and contraction of voluntary muscle levator
palpabera superioris produces this sign.
JOFFROY’S SIGN:
In head bent down position when eyes looked up absent forehead
wrinkles.
MOEBIUS SIGN:
The eyeball fails to converge, due lymphocytic infiltration of rectus
and inferior oblique muscle results in diplopia.
NAFFZIGER’S SIGN:
The patient examined from behind patient in sitting position with neck
fully extended the protruded eyeball is visualised.
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THYROID DERMOPATHY:
It is pretibial myxoedema, characterised by thickening of skin by
deposition of hyaluronic acid in dermis and subcutis.
TOXIC NODULAR GOITRE:
It present as simple goitre for long time before, hyperthyroidism
commonly in middle aged or elderly women associated with eye signs.
Secondary thyrotoxicosis features as been seen. Toxic nodular goitre, nodule
in goitre functions autonomously independent of TSH.
However in some cases one or more nodules are overactive and results in
hyperthyroidism.
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TOXIC ADENOMA :
A toxic nodule is a solitary overactive nodule as a part of generalised
nodularity or as toxic adenoma. The TSH receptor antibody does not play
any role it is autonomous hypertrophy and hyperplasia. The high level of
thyroid hormone results in suppression of TSH which results in inactive
nodule and gland. In normal thyroid gland consist of follicle lined by
cuboidal epithelium filled with colloid homogenous material, in
hyperthyroidism the cells became columnar epithelium and may them are
empty and others contain vacuolated colloid.
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NON FUNCTIONING GOITRE :
MULTINODULAR GOITRE :
The thyroid gland diffusely enlarged heterogenous, asymmetric
nodularity is seen, the cause is usually iodine deficiency. Intially the mass is
euthyroid by elevation in size of gland T3 T4 level progress to
hypothyroidism.
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SUBSTERNAL GOITRE:
The enlarged thyroid extends into thoracic, substernally. Mostly
substernal goitre is secondary because of Extension of multi nodular goitre.
Vascularity depends on inferior thyroid artery. But in primary is aberrant
tissue in anterior or posterior mediasternum depends on intrathoracic
vascularity.
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CLINICAL FEATURES
HYPOTHYROIDISM
1. Bradycardia
2. Cold extremities
3. Dry skin and hair
4. Periorbital puffiness
5. Hoarness of voice
6.Bradykinesis
7. Delayed relaxation phase of ankle jerks
SYMPTOMS:
1. Tiredness
2. Mental lethargy
3. Cold intolerance
4. Weight gain
5. Constipation
6. Menstrual disturbance
7. Carpal tunnel syndrome.
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HYPERTHYROIDISM:
1. Tiredness
2. Emotional liability
3. Heat intolerance
4. Weight loss
5. Excessive appetite
6. Palpitation
7. Tachycardia
8. Hot, moist palms
9. Exophthalmos
10. Eyelid lag/retraction
11. Agitation
12. Thyroid goitre and bruit.
MALIGNACIES:
PAPILLARY CARCINOMA:
Papillary carcinoma is most common thyroid Neoplasm with
excellent prognosis. More common in female patients particularly 30-50
years of age. Most common risk factor is ionising radiation exposure in
childhood for medical or from environmental source or thyroid malignancies
in families. Diagnosis can be made by Presence follicle filled with follicular
structures in some mixed with
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colloid and follicle of intra-nuclear inclusion bodies follicular grooves and
psammoma bodies, histologically in tumour there will be papillary
projections with orphan annie –eyed nuclei. The primary tumour can arise as
multiple foci in same lobe, the gland is rich in intrathyroidal lymph plexus so
lymphatic spread is more common. Extrathyroidal by infiltrating capsule and
spreading to surrounding trachea and oesophagus is rare. The treatment of
choice is high risk patient that is
1. More Than 50 Yrs of Age
2. Tumour Size Greater Than 4 Cm
3. FNAC Suspicious of Papillary Carcinoma
5. Family History
6. History of Radiation Exposure
To undergo near total or total thyroidectomy.
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MICROCARCINOMA (OCCULT CARCINOMA)
The tiny foci prevalence of papillary carcinoma is based thyroid
examined under microscope. The autopsy studies shows when thyroid
examined the incidence of papillary carcinoma 36% , the never progress to
became clinically significant. In some cases the thyroid appears normal but
there will be enlarged lymphnode or pulmonary metastasis. When the
primary tumour size of less than 1.5 cm called as occult but now when
tumour size less than 1 cm called as microcarcinoma.
FOLLICULAR CARCINOMA:
Follicular carcinoma is the second most common thyroid malignancy.
Most common in females of 3:1 ratio, of older age distribution 40-60yrs. It is
increased in incidence associated with iodine deficiency. They appear to be
capsulated but capsular and vascular space invasion is seen On
histopathology examination follicular cancer deposits in capsule, vascular
and lymphatics. The lymphatics involvement is less than 10% compared to
papillary thyroid cancer, prognosis is less favourable in follicular carcinoma.
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Treatment of choice is total thyroidectomy. Postoperatively radioiodine
ablation therapy can be done using iodine I 131.
HURTHLE CELL CARCINOMA
It is subtype of follicular carcinoma. It contains abundant oxyphilic
cells. It has worse clinical prognosis common in older age.
PROGNOSIS IN DIFFERNTIATED THYROID CANCER
There is excellent prognosis in differentiated thyroid carcinoma. The
prognosis depends on various factors most common is age at diagnosis, size
of tumour, metastasis, extrathyroidal spread or capsular transgression
(follicular carcinoma). Approximately 70 percent of patient risk of dying of
thyroid cancer due recurrence failure to eradicate all macroscopic disease at
first operation. The treatment of choice in this patient is total thyroidectomy
with adjacent nodal excision followed by radio iodine abalation with long
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term TSH suppression. The guidelines advocate routine total thyroidectomy
followed early reoperation and second lobectomy following the first
lobectomy with central compartment node dissection for all tumours greater
than 1 cm. Total Thyroidectomy facilitates use of radio iodine for post
operative scanning to detect and ablate metastases in lower thyrogloblin
level, local recurrence in thyroid contralateral lobe or thyroid bed is rare in
total lobectomy. When surgery is planned in differentiated thyroid carcinoma
image of neck with MRI or USG is done to identify nodal involvement and
plan for surgery Total thyroidectomy can be done tumour greater than 2 cm
with metastasis and nodal involved, for other cases lobectomy can done.
Functional selective node dissection of involved node level is performed if
required. Level 3-7 node is accessed by lateral extension of normal
thyroidectomy, if accessability to level is needed J shaped incision is done
the aim of our surgery is to remove macroscopic diseases. There difference
between central compartment dissection in patient without nodal
involvement to with nodal involvement. In diagnostic there will be unilateral
nodal dissection with preservation of thymus but in therapeutic dissection
requires clearance of all tissue to the level of innominate vein. Sometime it
may required to sacrifice recurrent laryngeal nerve, oesophagus and trachea.
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OPTIONAL MODALITIES
Thyroxine is commonly used in dose of 100-200 mcug daily to
suppress endogenous TSH production in all cases of differentiated thyroid
cancer due TSH dependant. TSH suppression is confirmed by measurement
when the level not <.1mu/L then the dose of thyroxine is inadequate. Most
patients require thyroid supplementation following total thyroidectomy and
near total thyroidectomy. Patient with metastasis may require repeated dose
of radio iodine for scanning and therapy so tri-iodothyronine can used
because of shorter duration of action. The patient is spared 4 weeks to
develop thyroid insufficiency . instead of thyroxine withdrawl  recombinant
TSH can be for 48 hours period for maximum iodine uptake which is more
expensive.
In radio isotope scan when metastasis take more radioisotopes they
can treated with large dose of radioiodine. The proper scanning method the
normal thyroid tissue must have been abalated either by surgery or
radioiodine so the patient must be hypothyroid to improve uptake. The
radiodine are used in unresctable, metastatic disease, local recurrence. A
high dose radio iodine given followed whole body scan 10 days later to
allow decay of activity. The solitary metastasis is treated by external
radiotherapy. When metastasis is treated the serum thyroglobulin level and
protocol decides when scan to be repeated.
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Thyroglobulin is used as indicator in cases of follow up in detection of
metastatic disease in patient who have undergone surgery for papillary or
follicular malignancy. This indicator can be used following lobectomy or
total thyroidetomy were endogenous TSH production is suppressed by
Thyroxine. When antithroglobulin antibodies found thyroglobulin as serum
marker for recurrence becomes invalid .
MEDULLARY CARCINOMA
It accounts for 4-8% of thyroid cancer, arises from parafollicular cells
or C cells. Commonly associated with MEN 2A and MEN 2B. It is
diagnosed by finding of increased calcitonin level. Calcitonin as been used
as indicator which falls on resection and increase on recurrence. Most
patient present with diarrhoea due increased level of 2-hydroxy tryptamine
or prostaglandin produced by tumour cells. The medullary carcinoma thyroid
can occur in combination with adrenal phaeochromocytoma and
hyperparathyroidism commonly in children and young adults. Involvement
of lymphnode occurs in 40-50 % of cases and blood borne metastasis is
common. The treatment is total Thyroidectomy with therapeutic or
prophylactic dissection of bilateral and central cervical node. The patient
with RET mutation are more prone for development of medullary cancer in
later life. In some cases prophylactic thyroidectomy done in infants with
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mutation, all cases be planned for thyroidectomy should be undergone
screening Pheochromocytoma.
ANAPLASTIC THYROID CANCER:
It is 1% of thyroid malignancies. Commonly seen in elderly women
the tumour spread by lymphatics and blood stream and local infiltration is
early features. The survival calculated in months. Some of this aggressive
lesion present as tracheal obstruction requires decompression by
isthumectomy, tracheostomy is avoided radiotherapy and chemotherapy are
little importance patient present with enlarging neck mass, cervical
tenderness, dysphagia in older patient and prognosis is very bad. On
microscopic examination giant cells with intranuclear cytoplasmic
invagination has been seen. Surgery is tempered because on diagnosis itself
there is 10% metastasis distantly including lungs.
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LYMPHOMA
It is rare and develops from pre-existing Hashimotos thyroiditis
commonly seen in females 4:1 ratio. Patient present with fever dysphagia
,hoarness of voice. It is non Hodgkins lymphoma B cell origin. patient
treated with CHOP (cyclophosmide, hydoxy actinomycin, vincristine
,prednesolone) regimen. Surgical resection include total thyroidectomy, near
total thyroidectomy. In patient with tracheal compression isthumectomy is
most appropriate treatment.
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INVESTIGATION
1. TSH –Thyroid stimulating hormone to assess pituitary-thyroid
feedback. It has been used to delineate the hypothyroidism,
hyperthyroidism from euthyroidism.
2. SERUM T3 T4- To estimate free T3 T4, serum protein bound T3 and
T4.
3. CALCITONIN-In isolates medullary carcinoma or MEN type2
suspected calcitonin estimation is done.
4. RADIOACTIVE IODINE UPTAKE:
Screening of solitary nodular goitre I121 is given after 24 hrs, uptake
is calculated using radioscintigrapy usually 15-30% uptake. I121 is used
because of short half life and lesser radiation exposure.
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5. THYROID AUTO ANTIBODIES LEVEL :
It is used in detection of auto immune thyroidism. The commonly
used autoantibodies are Thyroid stimulating immunoglobulin,
antimicrosomal antibodies, antithyroid peroxidase antibodies.
ROUTINE INVESTIGATION:
 Haemoglobin
 Total count, Differential count, ESR
 Random Blood sugar
 Urea, creatinine
 Urine Routine
 ECG
 X-ray chest, x- ray neck
ULTRASOUND NECK
High frequency probe in 7.5 Hz to 16MHz ranges are used. It is used
to differentiate cystic or solid, if solid number of nodule size of nodule
,position of nodule are detected. It can detect malignancy by
microcalcification, hypervascularity, infilterative irregular margins,
hypoechoic surrounding margins.
INDIRECT LARYNGOSCOPE
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To rule out status of vocal cords. In some even voice can be normal
but there will be unilateral vocal cord paralysis due to mumps or other viral
infections.
FINE NEEDLE ASPIRATION CYTOLOGY:
It is single most important test can be performed with or without
ultrasound guidance. The nodule difficult to palpitate and for cystic or solid
USG guided aspiration can be done. The syringe with 23G needle used for
aspiration several passes are made while aspirating, after releasing the
suction on syringe the needle withdrawn and cells are placed in dry glass
slide some immersed in 70% alcohol, while other dried in air, some placed in
90% alcohol for cytopsin or cell pellets. The slide stained with papanicoloau
stain or wright’s stain examined under microscope. Following FNAC the
nodules are categorised into the following group.Benign-63%,suspicious-
21%,malignancy-6% ,non diagnostic – 8%. The false positive 1% ,false
negative 3%.in non diagnostic condition it is repeated. The benign leision
include the cyst and colloid nodule. The risk of malignancy in this patient
<3%. The diagnosis of malignancy relies on demonstrating capsular or
vascular invasion, features cannot be determined by FNAC.
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MANAGEMENT
TREATMENT:
Primary Hypothyroidism-levothyroxine is safe and effective, it is
available oral, intramuscular and iv preparation. The dose calculated based
on Body weight and started with low dose and increased. Most patient
tolerate oral preparation once daily.
HYPERTHYROIDISM:
Patient treated with Beta blockers-Reduces adrenergic symptoms of
thyrotoxicosis. PROPYLTHIOURACIL - Blocks organification of iodine,
inhibits coupling, peripheral conversion of T4 to T3 METHIMAZOLE-
Inhibits coupling CORTICOSTEROIDS - Inhibits synthesis of
autoantibodies. IODINE131-Radioactive abalation therapy it abalates
thyroid within 6-8 weeks.
62
SURGERY:
Total thyroidectomy:
Sub total thyroidectomy
Near-total thyroidectomy
THYROIDECTOMY:
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All patient before undergoing surgery undergoes investigation like thyroid
profile, blood routine, ENT opinion regarding vocal cord status, ECG and
cardiologist opinion. Patient lies in supine position with sand bag under
inter-scapular region hyper-extended neck with head ring makes maximal
exposure of thyroid region. A kocher transverse skin crease incision done
midway between cricoid cartilage and supra-sternal notch extending lateral
border of sternocleidomastoid muscle from one side to other. Skin,
subcutaneous, platysma incised upper and lower flap raised, upper flap upto
thyroid cartilage lower flap upto suprasternal notch. Deep fascia opened with
care strap muscles are retracted. In some condition on operating on large
goitre strap muscle divided in upper part to safeguard ansa cervicalis. The
anterion jugular vein ligated. Thyroid gland enclosed in pretracheal fascia
opened gland exposed searched lateral to gland middle thyroid vein draining
into internal jugular vein, ligated and divided. The middle thyroid vein, the
vein without artery. The gland can be mobilised medially. The upper part of
gland dissected for superior pedicle identified and ligated artery and vein
separately to prevent AV fistula formation. The pedicle is cut after external
laryngeal nerve visualisation. The superior and inferior parathyroid gland
visualised on dissection which is golden brown or orange brown in colour,
the receive its blood supply from inferior thyroid artery. The recurrent
laryngeal nerve dissected in riddles triangle formed medially trachea
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laterally carotid artery and above inferior thyroid artery the nerve course
towards larynx  and enter greater cornu of thyroid cartilage. In some patient
the thyroid extend posteriorly close to ligamentum berry is called
zuckerkandl tubercle. The recurrent laryngeal nerve runs between trachea
and zuckerkandle tubercle or main gland. The 4th aortic arch failure results in
some cases for development of non recurrent laryngeal nerve on right side
which directly arise from vagus and and enter larynx at inferior horn of
thyroid cartilage. The ligamentum berry and recurrent laryngeal nerve are in
close contact. The inferior thyroid artery arise from thyrocervical trunk
ascends up at carotid turns towards midline and supplies the gland, so
ligation of inferior thyroid artery at the capsular level to be done, the thyroid
gland dissected and removed. Haemostasis obtained, suction drain placed
and fixed, wound closed with sub-cuticular sutures, dressing done.
MINIMALLY INVASIVE TECHNIQUE IN THYROIDECTOMY
A small 3-cm incision is done, the flap not raised minimal dissection
to remove thyroid through the incision then pretracheal and paratracheal
dissection done. For visualisation video assisting can be used. The gland can
be approached through endoscopy through axilla. Supraclavicular anterior
chest and brest. In this approaches around 30 mm incision are done and
multiple trocars are inserted co2 isufflated upto 4mmhg the working space
created the muscle
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retracted and vessels are clips applied, the benefit over open approach not
established.
INTRATHORACIC GOITRE SURGICAL REMOVAL
The thyroid is considered mediastinal goitre when 5o% of thyroid in
intrathoracic. It may be primary or secondary in primary goitre arise from
ectopic thyroid in chest and it derives blood supply from intrathoracic
vessels. In secondary the thyroid tissue extends from neck and derives blood
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supply from superior and inferior thyroid vessels. Intrathoracic goitre
removed by median sternotomy upto 3rd rib and divided. The goitre is
approached by neck incision vessels like superior and inferior pedicle,
middle thyroid vein identified and dissected.
CENTRAL AND LATERAL NECK DISSECTION
The central compartment lies medial to carotid vessels the nodes in
this area are involved in malignancy like papillary, medullary and hurthle
cell carcinoma, so lymphnode should be removed during thyroidectomy.
Care to be taken to preserve recurrent laryngeal nerve and parathyroid gland.
Ipsilateral modified radical neck dissection done in medullary carcinoma
when thyroid lesion is more than 1 cm, as prophylactic clearance. The same
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thyroid incision can be used for modified radical neck dissection but
extended laterally upto trapezius (mc fee incision), the fibrofatty tissue along
internal jugular vein level 2,3,4 and posterior triangle removed, the internal
jugular vein, spinal acessary nerve, sternomastoid muscle are preserved
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COMPLICATION
HAEMARRHAGE
The reactionary Haemorrhage from one of thyroid arteries results in
tension Haematoma deep to cervical fascia. Sometimes haemorrhage from
thyroid vein or thyroid remnant may be responsible. It requires urgent
decompression by opening the layer of wound, a subcutaneous haematoma
or collection of serum requires urgent evacuation which is the life saving
procedure.
RESPIRATORY DEPRESSION
This is seen in condition associated with tracheamalacia, due to
kinking or collapse of trachea. Some cases are due laryngeal oedema. The
tension haematoma produces laryngeal oedema. During intubation and
surgical manipulation or highly vascular results in laryngeal oedema. The
unilateral or bilateral vocal cord paralysis does not cause immediate post
operative obstruction. In tension haematoma trachea to intubated and tension
haematoma should be removed. If needed endotracheal  intubation can be
left for weeks ,steroid can be added as antiodematic measures, sometimes
rarely tracheostomy can be done. When laryngeal odema is present
intubation is difficult so wide bore needle tracheostomy can done, as
temporary measures.
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RECURRENT LARGNGEAL PARALYSIS AND VOICE
CHANGE
Recurrent laryngeal nerve injury commonly unilateral and rarely
bilateral, transient or permanent. Postoperative laryngoscopy reveals vocal
cord paralysis which is assessed by voice and cough. For first 4 weeks vocal
cord assessment wants to be done. Recurrent nerve palsy is 2% in first
3months which declines to .5% at three months. When surgery performed by
visualising RLN then permanent paralysis is very rare. Injury to superior
laryngeal nerve is common because of close association with superior
thyroid vessels. When it injured results in loss of tension in vocal cord with
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diminished power and range in voice. Patient should be advised about voice
change postoperatively even without nerve injury.
THYROID INSUFFICIENCY:
Following subtotal thyroidectomy patient develops thyroid
insufficiency especially when operated in thyroiditis because of autoimmune
destruction of thyroid cells, commonly seen in graves disease. In surgeries
for toxic adenoma thyroid insufficiency is very rare because there in no
autoimmune disease.
PARATHYROID INSUFFICIENCY:
It is due to removal of parathyroid gland or infarction through
damage to parathyroid end artery results in parathyroid insufficiency. Then
inadvertent removal vascular injury is more common. Less than 1% suffer
with permanent Hypoparathyroidism. Usually 2-3 days rarely 2-3 weeks
patient present with features of Hypocalcemia.
THYROID CRISIS(STORM):
It is acute exacerbation of hyperthyroidism. Most commonly seen
when patient with hyperthyroidism taken for surgery without adequate
preparation. Patient needed supportive treatment for dehydration,
hyperpyrexia, and restlessness. The patient requires administration of
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intravenous fluids, cooling patient with ice packs, administration of oxygen,
diuretics for cardiac failure,digoxin for uncontrolled atrial fibrillation,
sedation and intravenous Hydrocortisone, the specific treatment is
carbimazole 10-20mg 6th hourly, sodium iodide or lugols iodine or
proparnolol intravenously or orally will block beta adrenergic effect.
Wound infection:
Sometimes cellulitis or subcutaneous or deep cervical abscess
requires antibiotics.
HYPERTROPHIC OR KELOID SCAR:
Along incision line rarely develop keloid common in dark skinned
individuals especially over sternum, corticosteroid intradermal injection
given monthly once or scar revision surgery done.
Stitch Granuloma:
When non absorbable silk like suture material used more prone for
sinus formation.
74
POST OPERATIVE CARE:
About 20 percent patients develop transient hypocalcemia post
operatively requires oral calcium 1gm three or four times a day. If symptoms
severe patient may treated with intravenous calcium infusion. As routine
parathyroid insufficiency assessed by measuring serum calcium level 4
weeks after operation.
75
CONCLUSION
 The best modality of investigation for thyroid based on our study found to
be Fine needle aspiration cytology, easy to perform and cheaper.
 In our study conducted among the patient visiting our Hospital  the
commonest thyroid disease is solitary nodular goitre
 Out of 100 patients 92 females and 8 males were affected which shows
disease of female predominance
 Most  of affected people were middle aged 30-60 years, which shows
disease of mid age group
 Most of lesion benign 79 cases out of 100  which proves benign nodules
are common presentation
 The reported 21 malignant cases papillary carcinoma of 14 cases and 7
follicular carcinoma, which show the common thyroid malignancy is
papillary carcinoma
 The reported 8 cases in males 3 were malignant which shows
propionately solitary nodule in male are more malignant
 The patients with benign lesion underwent hemithyroidectomy of 79
cases, while patient with malignant and suspicious underwent total
thyroidectomy with lymphnode dissection.
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PROFORMA
A FOLLOW UP STUDY BY FINE NEEDLE ASPIRATION CYTOLOGY IN
SOLITARY NODULAR GOITRE IN GVMCH
NAME :
AGE :
SEX :               MALE                     FEMALE
OCCUPATION :
ADDRESS :
IP/OP NO. :
CBC :
RFT :
FASTING BLOOD SUGAR :
POST PRANDIAL BLOOD SUGAR :
THYROID PROFILE :
ECG :
USG NECK :
SYSTOLIC BP :
DIASTOLIC BP :
HEIGHT : WEIGHT : BMI :
FNAC Report :
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PATIENT CONSENT FORM
A FOLLOW UP STUDY BY FINE NEEDLE ASPIRATION CYTOLOGY IN
SOLITARY NODULAR GOITRE IN GVMCH
STUDY CENTRE :
PATIENT’S NAME :
PATIENT’S AGE :
IDENTIFICATION NUMBER :
I confirm that I have understood the purpose and procedure of the above study. I
have the opportunity to ask questions and all my questions and doubts have been
answered to my complete satisfaction.
I understand that my participation in the study is voluntary and that I am free to
withdraw at any time without giving reason, without my legal rights being affected.
I understand that the sponsor of the clinical study, others working on the sponsor’s
behalf, the ethical committee and the regulatory authorities will not need my permission
to look at my health records, both in respect of the current study and any further research
that may be conducted in relation to it, even if I withdraw from the study I agree to this
access. However I understand that my identity would not be revealed in any information
released to third parties or published, unless as required under the law. I agree not to
restrict the use of any data or results that arise from this study.
I hereby consent to participate in this study.
I hereby give permission to undergo complete clinical examination and diagnostic
tests including haematological, biochemical, radiological tests.
Signature/thumb impression:
Patient’s name and address:                                             Place:                              Date:
Signature of the investigator:
Name of the investigator:                                                  Place:                              Date:
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21/07/2016 - 08:19 PM 08-07-2016 45273 MAHALAXMI Female 21 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
26/08/2016 - 12:49 PM 14/09/2016 62609 SUGUNA Female 32 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
26/08/2016 - 09:40 AM 23/09/2016 62555 VAJRAM Male 35 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
26/09/2016 - 11:05 AM 10-08-2016 69816 PADMAVATHI Female 41 normal solitary nodule solitary nodule Left lobe BENIGN
adenamatous
hyperplasia
Hemithyroidectomy
17/10/2016 - 10:03 PM 11-04-2016 74893 THULASI Female 35 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
06/11/2016 - 08.50 AM 16/11/2016 79661 VANITHA Female 22 normal solitary nodule solitary nodule Isthumus BENIGN cystic Hemithyroidectomy
11/09/2016 - 12:36 PM 21/11/2016 80438 ,AHALAKSHMI Female 36 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
15/11/2016 - 11:24 AM 28/11/2016 81738 ARULMOZHI Female 39 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
12/01/2016 - 10:45 AM 12-12-2016 85447 SARASWATHI Female 42 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
08/12/2016 - 10:07 AM 27/12/2016 86822 SIVAGAMI Female 44 normal solitary nodule solitary nodule Right lobe BENIGN
adenamatous
hyperplasia
Hemithyroidectomy
29/11/2016 - 11.24 AM 27/12/2016 84964 KALAIVANI Female 51 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
24/12/2016 - 10:08 AM 01-09-2017 90319 JAYANTHI Female 23 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
12/08/2016 - 09:06 AM 18/01/2017 86807 KANCHANAMMAL Female 53 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
15/02/2017 - 11:54 AM 25/02/2017 9515 KRISHNAVENI Female 52 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
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15/02/2017 - 11:28 AM 03-01-2017 9505 VALLI Female 51 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
13/02/2017 - 02:02 PM 13/03/2017 9077 JAYA Female 36 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
03/02/2017 - 09:32 AM 16/03/2017 12941 KAMSALA Female 24 normal solitary nodule solitary nodule Right lobe BENIGN
adenamatous
hyperplasia
Hemithyroidectomy
20/03/2017 - 12:54 AM 04-04-2017 16833 ORANGE AMMAL Female 69 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
31/03/2017 - 10:14 AM 04-06-2017 19882 BANU YASHMIN Female 37 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
04/04/2017 - 11:30 AM 05-02-2017 20601 AMSA Female 47 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
05/02/2017 - 10:32 AM 05-02-2017 26789 KASTHURI Female 66 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
05/09/2017 - 09:40 AM 26/05/2017 28320 KASTHURI Female 48 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
19/05/2017 - 12:28 PM 31/05/2017 30885 VASANTHA Female 27 normal solitary nodule solitary nodule Left lobe BENIGN cystic Hemithyroidectomy
22/05/2017 - 9.24 PM 06-06-2017 31563 SHANTHI Female 39 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
06/05/2017 - 09:43 AM 21/06/2017 34953 LAXMI Female 21 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
06/01/2017 - 12:53 AM 24/06/2017 34105 SOWMIYA Female 41 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
28/06/2017 - 12:44 AM 30/06/2017 40914 ASHOK KUMAR Male 22 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
08/08/2016 - 02:19 PM 18/08/2016 49303 VIMALA Female 49 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
15/08/2016 - 08:37 AM 22/08/2016 50901 JOTHI Female 28 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
23/11/2016 - 10:56 AM 12-09-2016 83644 SUGANYA Female 54 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
12/09/2016 - 11:21 AM 17/12/2016 87119 UNNAMALAI Female 52 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
28/12/2016 - 11:53 AM 31/12/2016 91118 SURESH Male 24 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
29/12/2016 - 10:16 AM 14/01/2017 91319 MAHESHWARI Female 51 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
01/11/2017 - 11:24 AM 28/01/2017 2232 RENUGA Female 61 normal solitary nodule solitary nodule Left lobe BENIGN adenamatous Hemithyroidectomy
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hyperplasia
30/01/2017 - 11:06 AM 14/02/2017 6067 SHARMILA Female 41 normal solitary nodule solitary nodule Right lobe BENIGN
adenamatous
hyperplasia
Hemithyroidectomy
24/01/2017 - 10:25 AM 16/02/2017 4892 RAMU Male 26 normal solitary nodule solitary nodule Left lobe MALIGNANT
follicular
carcinoma
Total thyroidectomy
02/06/2017 - 09:45 AM 21/02/2017 7570 LALITHA Female 44 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
02/10/2017 - 12:05 AM 27/02/2017 8515 JAYA Female 62 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
15/02/2017 - 11.58 AM 03-04-2017 8516 KUMARI Female 57 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
09/03/2017 - 10.59 AM 20/03/2017 14909 DHARMALINGAM Female 52 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
22/03/2017 - 12:11 PM 04-03-2017 17285 KANTHA Female 33 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
28/04/2017 - 10:37 AM 16/05/2017 25925 UMA Female 38 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
20/05/2017 - 09:45 AM 24/05/2017 31081 RAMANI Female 29 normal solitary nodule solitary nodule Right lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
19/05/2017 - 12:25 PM 30/05/2017 30883 SOWBAKKIYAM Female 39 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
16/05/2017 - 12:03 AM 06-05-2017 30020 SUSILA Female 32 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
28/06/2017 - 10:46 AM 07-06-2017 40863 NEELAVATHI Female 43 normal solitary nodule solitary nodule Right lobe BENIGN
adenamatous
hyperplasia
Hemithyroidectomy
21/07/2016 - 08:19 PM 08-07-2016 45273 MAHALAXMI Female 21 normal solitary nodule solitary nodule Left lobe MALIGNANT
follicular
carcinoma
Total thyroidectomy
26/08/2016 - 12:49 PM 14/09/2016 62609 SUGUNA Female 44 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
26/09/2016 - 11:05 AM 10-08-2016 69816 PADMAVATHI Female 72 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
17/10/2016 - 10:03 PM 11-04-2016 74893 THULASI Female 49 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
06/11/2016 - 08.50 AM 16/11/2016 79661 VANITHA Female 50 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
11/09/2016 - 12:36 PM 21/11/2016 80438 ,AHALAKSHMI Female 22 normal solitary nodule solitary nodule Left lobe MALIGNANT papillary Total thyroidectomy
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carcinoma
15/11/2016 - 11:24 AM 28/11/2016 81738 ARULMOZHI Female 55 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
12/01/2016 - 10:45 AM 12-12-2016 85447 SARASWATHI Female 25 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
08/12/2016 - 10:07 AM 27/12/2016 86822 SIVAGAMI Female 51 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
29/11/2016 - 11.24 AM 27/12/2016 84964 KALAIVANI Female 21 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
16/12/2016 - 12:08 AM 27/12/2016 88612 MUNIYAN Male 43 normal solitary nodule solitary nodule Left lobe MALIGNANT
follicular
carcinoma
Hemithyroidectomy
24/12/2016 - 10:08 AM 01-09-2017 90319 JAYANTHI Female 52 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
12/08/2016 - 09:06 AM 18/01/2017 86807 KANCHANAMMAL Female 20 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
15/02/2017 - 11:54 AM 25/02/2017 9515 KRISHNAVENI Female 29 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
15/02/2017 - 11:28 AM 03-01-2017 9505 VALLI Female 53 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
13/02/2017 - 02:02 PM 13/03/2017 9077 JAYA Female 21 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
03/02/2017 - 09:32 AM 16/03/2017 12941 KAMSALA Female 54 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
20/03/2017 - 12:54 AM 04-04-2017 16833 ORANGE AMMAL Female 24 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
31/03/2017 - 10:14 AM 04-06-2017 19882 BANU YASHMIN Female 25 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
04/04/2017 - 11:30 AM 05-02-2017 20601 AMSA Female 26 normal solitary nodule solitary nodule Right lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
05/02/2017 - 10:32 AM 05-02-2017 26789 KASTHURI Female 55 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
05/09/2017 - 09:40 AM 26/05/2017 28320 KASTHURI Female 66 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
19/05/2017 - 12:28 PM 31/05/2017 30885 VASANTHA Female 44 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
22/05/2017 - 9.24 PM 06-06-2017 31563 SHANTHI Female 28 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
06/05/2017 - 09:43 AM 21/06/2017 34953 LAXMI Female 63 normal solitary nodule solitary nodule Left lobe MALIGNANT
follicular
carcinoma
Total thyroidectomy
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06/01/2017 - 12:53 AM 24/06/2017 34105 SOWMIYA Female 43 normal solitary nodule solitary nodule Right lobe BENIGN
adenamatous
hyperplasia
Hemithyroidectomy
28/06/2017 - 12:44 AM 30/06/2017 40914 ASHOK KUMAR Male 42 normal solitary nodule solitary nodule Right lobe BENIGN cystic Hemithyroidectomy
15/09/2016 - 02.10 PM 17/09/2016 67216 GOUSIGA Female 47 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
14/09/2016 - 11:31 AM 23/09/2016 66896 USHA Female 48 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
11/08/2016 - 12:23 PM 14/11/2016 80194 VIJIYA Female 45 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
16/11/2016 - 08:45 AM 28/11/2016 81930 JOTHI Female 20 normal solitary nodule solitary nodule Right lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
16/12/2016 - 11.31 AM 31/12/2016 888593 AGILANDAM Female 49 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
01/02/2017 - 11:54 AM 14/01/2017 282 KUMARI Female 42 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
21/01/2017 - 10:13 AM 28/01/2017 4270 SIVAGAMI Female 41 normal solitary nodule solitary nodule Right lobe MALIGNANT
papillary
carcinoma
Hemithyroidectomy
30/01/2017 - 12:17 AM 02-10-2017 6116 MANI Male 51 normal solitary nodule solitary nodule Isthumus BENIGN colloid Hemithyroidectomy
02/08/2017 - 12:07 AM 15/02/2017 8093 YASMIN Female 58 normal solitary nodule solitary nodule Left lobe MALIGNANT
follicular
carcinoma
Total thyroidectomy
16/02/2017 - 10:46 AM 03-06-2017 9697 GOWRI Female 53 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
15/02/2017 - 11:41 AM 03-07-2017 9509 VENKATESH Male 62 normal solitary nodule solitary nodule Right lobe MALIGNANT
papillary
carcinoma
Hemithyroidectomy
17/03/2017 - 10.15 AM 24/03/2017 16200 BANU Female 42 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
20/03/2017 - 03:58 PM 27/03/2017 16873 VASANTHA Female 44 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
21/03/2017 - 09:28 AM 28/03/2017 17012 MUNIYAMMA Female 65 normal solitary nodule solitary nodule Left lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
03/01/2017 - 11:27 AM 30/03/2017 12777 POONGAVANAM Female 56 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
04/01/2017 - 10:47 AM 04-07-2017 20077 HAVAMMA Female 57 normal solitary nodule solitary nodule Right lobe MALIGNANT papillarycarcinoma Total thyroidectomy
89
04/04/2017 - 03:52 PM 15/04/2017 20658 MANJULA Female 53 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
20/04/2017 - 01:05 PM 05-02-2017 24197 RANI Female 27 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
26/04/2017 - 10:21 AM 05-06-2017 25467 RENUKA Female 46 normal solitary nodule solitary nodule Right lobe MALIGNANT
follicular
carcinoma
Total thyroidectomy
14/05/2017 - 09:06 AM 15/05/2017 29507 USHA Female 42 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
08/05/2017 - 03.30 PM 17/05/2017 28167 ELLAMMAL Female 25 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
23/05/2017 - 09:11 AM 23/05/2017 31861 LAKSHMI Female 47 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
06/07/2017 - 10:19 AM 15/06/2017 35511 REKKA Female 48 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
08/09/2017 - 11:55 AM 08-11-2017 51244 MEHARAJ BEE Female 47 normal solitary nodule solitary nodule Right lobe MALIGNANT
papillary
carcinoma
Total thyroidectomy
05/09/2016 - 09.57 AM 09-09-2016 64556 PRIYA Female 44 normal solitary nodule solitary nodule Left lobe BENIGN colloid Hemithyroidectomy
02/06/2017 - 11:52 AM 14/02/2017 7612 REVATHI Female 52 normal solitary nodule solitary nodule Right lobe BENIGN colloid Hemithyroidectomy
